These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4205586)

  • 1. Smallpox vaccination and its consequences: first experiences with the highly attenuated smallpox vaccine "MVA".
    Stickl HA
    Prev Med; 1974 Mar; 3(1):97-101. PubMed ID: 4205586
    [No Abstract]   [Full Text] [Related]  

  • 2. [MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's transl)].
    Stickl H; Hochstein-Mintzel V; Mayr A; Huber HC; Schäfer H; Holzner A
    Dtsch Med Wochenschr; 1974 Nov; 99(47):2386-92. PubMed ID: 4426258
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
    Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary vaccination against smallpox after preliminary vaccination with the attenuated vaccinia virus strain MVA and the use of a new "vaccination stamp"].
    Stickl H; Hochstein-Mintzel V; Huber HC
    Munch Med Wochenschr; 1973 Aug; 115(35):1471-3. PubMed ID: 4740817
    [No Abstract]   [Full Text] [Related]  

  • 5. Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.
    Wyatt LS; Earl PL; Eller LA; Moss B
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4590-5. PubMed ID: 15070762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.
    Earl PL; Americo JL; Wyatt LS; Eller LA; Whitbeck JC; Cohen GH; Eisenberg RJ; Hartmann CJ; Jackson DL; Kulesh DA; Martinez MJ; Miller DM; Mucker EM; Shamblin JD; Zwiers SH; Huggins JW; Jahrling PB; Moss B
    Nature; 2004 Mar; 428(6979):182-5. PubMed ID: 15014500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral vaccination against smallpox (on the return of smallpox vaccination)].
    Vorob'ev AA; Podkuĭko VN; Maksimov VA
    Vestn Ross Akad Med Nauk; 2003; (1):5-10. PubMed ID: 12608077
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral immunization against smallpox.
    Hochstein-Mintzel V; Stickl H; Huber HC
    Dev Biol Stand; 1976; 33():260-6. PubMed ID: 182585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Single Vaccination of Nonhuman Primates with Highly Attenuated Smallpox Vaccine, LC16m8, Provides Long-term Protection against Monkeypox.
    Iizuka I; Ami Y; Suzaki Y; Nagata N; Fukushi S; Ogata M; Morikawa S; Hasegawa H; Mizuguchi M; Kurane I; Saijo M
    Jpn J Infect Dis; 2017 Jul; 70(4):408-415. PubMed ID: 28003603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Freeze-dried live attenuated smallpox vaccine prepared in cell culture "LC16-KAKETSUKEN": Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice.
    Nishiyama Y; Fujii T; Kanatani Y; Shinmura Y; Yokote H; Hashizume S
    Vaccine; 2015 Nov; 33(45):6120-7. PubMed ID: 26455406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single vaccination with non-replicating MVA at birth induces both immediate and long-term protective immune responses.
    Cheminay C; Körner J; Bernig C; Brückel M; Feigl M; Schletz M; Suter M; Chaplin P; Volkmann A
    Vaccine; 2018 Apr; 36(18):2427-2434. PubMed ID: 29599088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of current smallpox vaccines].
    Maksiutov RA; Gavrilova EV; Shchelkunov SN
    Vopr Virusol; 2011; 56(6):4-8. PubMed ID: 22359941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.
    Volz A; Jany S; Freudenstein A; Lantermann M; Ludwig H; Sutter G
    Viruses; 2018 Jan; 10(1):. PubMed ID: 29300297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Our experiences with the 2-stage method of vaccination against smallpox (MVA virus pre-vaccination)].
    Rudkowski Z; Remion J; Saraczyńska E
    Pediatr Pol; 1976 May; 51(5):497-503. PubMed ID: 1272640
    [No Abstract]   [Full Text] [Related]  

  • 15. [Problems of oral smallpox vaccination].
    Stickl H
    Arzneimittelforschung; 1972 Oct; 22(10):1800-1. PubMed ID: 4351963
    [No Abstract]   [Full Text] [Related]  

  • 16. Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaques.
    Edghill-Smith Y; Venzon D; Karpova T; McNally J; Nacsa J; Tsai WP; Tryniszewska E; Moniuszko M; Manischewitz J; King LR; Snodgrass SJ; Parrish J; Markham P; Sowers M; Martin D; Lewis MG; Berzofsky JA; Belyakov IM; Moss B; Tartaglia J; Bray M; Hirsch V; Golding H; Franchini G
    J Infect Dis; 2003 Oct; 188(8):1181-91. PubMed ID: 14551889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccine.
    Phelps AL; Gates AJ; Hillier M; Eastaugh L; Ulaeto DO
    Vaccine; 2007 Jan; 25(1):34-42. PubMed ID: 16950548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge.
    Empig C; Kenner JR; Perret-Gentil M; Youree BE; Bell E; Chen A; Gurwith M; Higgins K; Lock M; Rice AD; Schriewer J; Sinangil F; White E; Buller RM; Dermody TS; Isaacs SN; Moyer RW
    Vaccine; 2006 Apr; 24(17):3686-94. PubMed ID: 16430997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Smallpox vaccination. What happened to prevaccination stuff?].
    Schmitz H
    MMW Fortschr Med; 2003 Jul; 145(27-28):13. PubMed ID: 14587180
    [No Abstract]   [Full Text] [Related]  

  • 20. TLR3 and TLR9 agonists improve postexposure vaccination efficacy of live smallpox vaccines.
    Israely T; Melamed S; Achdout H; Erez N; Politi B; Waner T; Lustig S; Paran N
    PLoS One; 2014; 9(10):e110545. PubMed ID: 25350003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.